SCHW

Summary

Establish a starter position in SCHW now to capture contrarian squeeze potential, but do not chase the overbought tape. Entry strategy: initiate ~25–50% of intended size at current levels (~$111.51), then add only on a pullback to the VWMA ($106.80) with a successful retest, or on a volume-confirmed breakout above $112.52. Key risk levels: stop-loss at $104.50 (below VWMA and Bollinger middle band, ~6% downside) for the full position; use a tighter $107.50 stop on the starter tranche to limit damage if the overbought condition resolves negatively. Time horizon: 5–20 trading days, targeting analyst consensus of $125, with the understanding that the path will be volatile (ATR ~$2.02). Size the position to allow adding on weakness without breaching portfolio risk limits.

The case

The decision is Buy, anchored in the convergence of accelerating fundamentals with washed-out sentiment. Revenue growth of 20.9% YoY, net income up 31.7%, NII up 19%, and — critically — declining interest expense demonstrate active liability management rather than passive rate-cycle benefit. Aggressive buybacks reducing share count 4.6% annually, a 20.3% ROE, and a forward P/E of 14.29 with PEG of 1.12 mean the market is not pricing in perfection; this is a growth story at a reasonable valuation.

The sentiment setup is textbook contrarian: zero bullish retail labels and a 1.72 put/call OI ratio at 52-week highs create genuine squeeze potential. The bear's concerns are real but overstated — the $10.6B AOCI loss sits in held-to-maturity securities (no forced mark-to-market), the 151.1 debt-to-equity ratio is contextually misleading for a broker-dealer whose liabilities are dominated by client payables, and the Linqto litigation shows no evidence of material financial impact. The claim that price above VWMA is a "profit-taking trigger" is technically backwards; price above VWMA is bullish confirmation.

We are deliberately not selecting Hold, despite the overbought technicals (RSI 77, price within 0.9% of the upper Bollinger Band, 16.5% above the 200 SMA). Our analysis warns against letting short-term technical extension override a verifiable fundamental catalyst. The MACD histogram compression (1.18 to 0.22) signals fading momentum acceleration, which argues for staged entry rather than full-size chasing — but it does not negate the medium-term thesis. The staged-entry discipline is incorporated: start small, add on VWMA retest or volume-confirmed breakout, and respect the stop. This converts a high-conviction directional view into a risk-managed position rather than a hedged non-decision.

What would weaken it

• Overbought technicals (RSI 77, price within 0.9% of upper Bollinger Band)
• MACD histogram compression (1.18 to 0.22) signals fading momentum
• Volatile path with ATR ~$2.02